sb 203580 has been researched along with benzylaminopurine in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (benzylaminopurine) | Trials (benzylaminopurine) | Recent Studies (post-2010) (benzylaminopurine) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 481 | 0 | 212 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Havlicek, L; Hyun, TK; Roitsch, T; Strnad, M | 1 |
1 other study(ies) available for sb 203580 and benzylaminopurine
| Article | Year |
|---|---|
Trisubstituted purines are useful tools for developing potent plant mitogen-activated protein kinase inhibitors.
Topics: Benzyl Compounds; Cells, Cultured; Imidazoles; Kinetin; Mitogen-Activated Protein Kinases; Plants; Protein Kinase Inhibitors; Purines; Pyridines; Signal Transduction; Solanaceae; Staurosporine; Structure-Activity Relationship | 2010 |